Frequency of urogynecological complications after pelvic radiotherapy

Czech version

Authors: Pavel Kabele ¹; Petr Hubka ¹; Markéta Polková ¹; Michal Zikán ¹; K. Votavová ²; Tomáš Brtnický ¹
Authors‘ workplace: Gynekologicko-porodnická klinika 1. LF UK a FN Bulovka, Praha ¹; Ústav radiační onkologie, 1. LF UK a FN Bulovka, Praha ²
Published in: Ceska Gynekol 2026; 91(3): 239-244
Category:
doi: https://doi.org/10.48095/cccg2026239

Overview

Pelvic radiotherapy is an integral part of treatment of many gynecological and other pelvic malignancies; however, it is associated with a risk of late urogynecological complications that can significantly affect the patients’ quality of life. The most common problems include lower urinary tract symptoms, particularly urgency, urinary incontinence, and radiation cystitis, as well as vaginal stenosis, dryness, dyspareunia, lymphedema, and chronic pelvic pain. The incidence of these complications depends on the total radiation dose, radiotherapy technique used, combination with surgical treatment or brachytherapy, and individual patient-related risk factors. The underlying pathophysiology involves post-radiation inflammatory and fibrotic changes, vascular damage, and impaired innervation of irradiated tissues. Diagnosis requires long-term follow-up, targeted medical history taking, physical examination, and the use of functional and imaging methods. Prevention and management are based on modern radiotherapy techniques, patient education, conservative and pharmacological approaches, physiotherapy, and in selected cases, surgical treatment. An essential component of care is also addressing psychosocial consequences, which significantly affect sexuality, partner relationships, and psychological well-being.

Keywords:

urinary incontinence – Quality of life – radiotherapy – radiation injuries – vaginal stenosis

Sources

1. Kirchheiner K, Pötter R, Tanderup K et al. Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2016; 94 (5): 1088–1098. doi: 10.1016/j.ijrobp.2015.12.363.

2. Hall E, Giaccia AJ. Radiobiology for the radiologist. 8th. ed. Philadelphia: Wolters Kluwer 2019.

3. Gunderson LL, Tepper JE. Clinical radiation oncology. 5. ed. Philadelphia: Elsevier 2020.

4. Joiner CM, van der Kogej A. Basic clinical radiobiology.6^th ed. USA: Florida: CRC Press 2025.

5. Bortfeld T, Schlecht W. Image-guided IMRT. Berlin: Springer 2009.

6. Loefler JS, Delaney TF. Proton and charged particle radiotherapy. Philadelphia: Lippincott Williams & Wilkins 2013.

7. Andreassen CN, Schack LN, Laursen LV et al. Radiogenomics –⁠ current status, challenges and future directions. Cancer Lett 2016; 382 (1): 127–136. doi: 10.1016/j.canlet.2016.01.035.

8. Azghadi S, Daly ME. Radiation and immunotherapy combinations in non-small cell lung cancer. Cancer Treat Res Commun 2021; 26 : 100298. doi: 10.1016/j.ctarc.2020.100298.

9. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1995; 340 (15): 1137–1143. doi: 10.1056/NEJM199904153401501.

10. Teh BS, Mai WY, Grant WH et al. Intensity Modulated Radiotherapy (IMRT) cecreases treatment-related morbidity and potentially enhances tumor control. Cancer Invest 2002; 20 (4): 437–451. doi: 10.1081/CNV-120002143.

11. Sandadi S, Tanner EJ, Khoury-Collado F et al. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications. Int J Gynecol Cancer 2013; 23 (3): 553–558. doi: 10.1097/IGC.0b013e3182849d53.

12. Zhang Y, Chen X, Wang X et al. Insights into ionizing radiation-induced bone marrow hematopoietic stem cell injury. Stem Cell Res Ther 2024; 15 (1): 222. doi: 10.1186/s13287-024-03853-7.

13. Wallis CJ, Mahar AL, Choo R et al. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. BMJ 2016; 352: i851. doi: 10.1136/bmj.i851.

14. Lind H, Waldenström AC, Dunberger G et al. Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Br J Cancer 2011; 105 (6): 737–745. doi: 10.1038/bjc.2011.315.

15. ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Oxford: Elsevier 2007.

16. Viswanathan AN, Lee LJ, Eswara JR et al. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer 2014; 120 (24): 3870–3883. doi: 10.1002/cncr.28849.

17. Chorbińska J, Krajewski W, Zdrojowy R. Urological complications after radiation therapy-nothing ventured, nothing gained: a narrative review. Transl Cancer Res 2021; 10 (2): 1096–1118. doi: 10.21037/tcr-20-2589.

18. Miles T, Johnson N. Vaginal dilation for preventing radiation-induced vaginal stenosis in women with cervical cancer. Cochrane Database Syst Rev 2010; 9 (9): CD007291. doi: 10.1002/14 651858.CD007291.pub2.

19. Jensen PT, Groenvold M, Klee MC et al. Early--stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer 2004; 100 (1): 97–106. doi: 10.1002/cncr.11877.

20. Frumovitz M, Sun CC, Schover LR et al. Quality of life and sexual functioning in cervical cancer survivors. J Cli Oncol 2005; 23 (30): 7428–7436. doi. 10.1200/JCO.2004.00.3996.

21. Chang WI, Kang HC, Wu HG et al. Lower extremity lymphedema in gynecologic cancer patients: propensity Score matching analysis of external beam radiation versus brachytherapy. Cancers (Basel) 2019; 11 (10): 1471. doi: 10.3390/cancers11101471.

22. Zelga P, Tchórzewski M, Zelga M et al. Radiation-induced rectovaginal fistulas in locally advanced gynaecological malignancies –⁠ new patients, old problem? Langenbecks Arch Surg 2017; 402 (7): 1079–1088. doi: 10.1007/s004 23-016-1539-4.

23. Yoo J, Choi JY, Hwang JH et al. Prognostic value of lymphoscintigraphy in patients with gynecological cancer-related lymphedema. J Surg Oncol 2014; 109 (8): 760–763. doi: 10.1002/jso. 23588.

24. Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn 2000; 19 (5): 553–564. doi: 10.1002/1520-6777 (2000) 19 : 5<553:: aid-nau2>3.0.co; 2-b.

25. Sapienza LG, Ning MS, de la Pena R et al. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer. Int J Gynecol Cancer 2020; 30 (10): 1535–1541. doi: 10.1136/ijgc-2020-001281.

26. Faye MD, Alfieri J. Advances in radiation oncology for the treatment of cervical cancer. Curr Oncol 2022; 29 (2): 928–944. doi: 10.3390/curroncol29020079.

27. Helissey C, Cavallero S, Brossard C et al. Chronic inflammation and radiation-induced cystitis: molecular background and therapeutic perspectives. Cells 2020; 10 (1): 21. doi: 10.3390/cells10010021.

28. Krhut J, Martan A, Jurakova M et al. Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up. Int Urogynecol J 2016; 27 (2): 301–305. doi: 10.1007/s00192-015-2834-2.

29. Dobberfuhl AD. Evaluation and treatment of female stress urinary incontinence after pelvic radiotherapy. Neurourol Urodyn 2019; 38 Suppl 4: S59–S69. doi: 10.1002/nau.23839.

30. Varytė G, Bartkevičienė D. Pelvic Radiation therapy induced vaginal stenosis: a review of current modalities and recent treatment advances. Medicina (Kaunas) 2021; 57 (4): 336. doi: 10.3390/medicina57040336.

31. Guedes TS, Gonçalves Guedes MB, de Castro Santana R et al. Sexual dysfunction in women with cancer: a systematic review of longitudinal studies. Int J Environ Res Public Health 2022; 19 (19): 11921. doi: 10.3390/ijerph191911921.

32. Bodurka DC, Sun CC. Sexual function after gynecologic cancer. Obstet Gynecol Clin North Am 2006; 33 (4): 621–630. doi: 10.1016/j.ogc.2006.09.006.

33. Sekse RJ, Dunberger G, Olesen ML, et al. Lived experiences and quality of life after gynaecological cancer –⁠ an integrative review. J Clin Nurs 2019; 28 (9–10): 1393–1421. doi: 10.1111/jocn.14721.

34. Monnery D, Droney J. Enhanced supportive care. Br J Hosp Med (Lond) 2024; 85 (3): 1–8. doi: 10.12968/hmed.2023.0416.